𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of TWIST as a regulator in giant cell tumor of bone

✍ Scribed by Shalini Singh; Isabella W.Y. Mak; Robert W. Cowan; Robert Turcotte; Gurmit Singh; Michelle Ghert

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
987 KB
Volume
112
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Giant cell tumor of bone (GCT) is an aggressive tumor consisting of multinucleated osteoclast‐like giant cells and proliferating osteoblast‐like stromal cells. Our group has reported that the stromal cells express high levels of the bone resorbing matrix metalloproteinase (MMP)‐13, and that this expression is regulated by the osteoblast transcription factor Runx2. The purpose of this study was to determine the upstream regulation of Runx2 in GCT cells. Using GCT stromal cells obtained from patient specimens, we demonstrated that TWIST, a master osteogenic regulator, was highly expressed in all GCT specimens. TWIST overexpression downregulated Runx2 expression whereas TWIST siRNA knockdown resulted in Runx2 and MMP‐13 upregulation. Interestingly, cells obtained from a GCT lung metastasis showed a reverse regulatory pattern between TWIST and Runx2. In mutational analysis, we revealed a point mutation (R154S) at the Helix2 domain of TWIST. This TWIST mutation may be an essential underlying factor in the development and pathophysiology of these tumors in that they lead to inappropriate TWIST downregulation of Runx2, arrested osteoblastic differentiation, and the maintenance of an immature and neoplastic phenotype. J. Cell. Biochem. 112: 2287–2295, 2011. Β© 2011 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Malignancy in giant cell tumor of bone
Malignancy in giant cell tumor of bone
✍ Franco Bertoni; Patrizia Bacchini; Eric L. Staals πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 1023 KB

## Abstract ## BACKGROUND The term __malignant giant cell tumor__ embraces multiple entities and therefore can be confusing. The goals of the current study were to define the clinicopathologic and histologic features of malignancy in giant cell tumors and to clarify the terminology. ## METHODS T

Cementation in the treatment of giant ce
Cementation in the treatment of giant cell tumor of bone
✍ S. Komiya; A. Inoue πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 571 KB

This study was designed to review the clinical experience of cementation in the treatment of giant cell tumor of bone and to clarify its biologic basis. Eleven patients treated by this technique had results rated excellent. No recurrences of the tumor were found. Serious complications, including inf

Giant cell tumor of the fronto-parietal
Giant cell tumor of the fronto-parietal bone. A case report
✍ Kayhan Kuzeyli; SΓΌleyman Baykal; Soner Duru; Savas Ceylan; Fadil AktΓΌrk πŸ“‚ Article πŸ“… 1995 πŸ› Springer-Verlag 🌐 English βš– 621 KB

Giant cell tumor of the skull is very rare clinical entity. This paper presents a case of giant cell tumor of the fronto-parietal bone and a brief review of the literature.

Giant cell tumor of bone. A cytologic st
Giant cell tumor of bone. A cytologic study of 24 cases
✍ Nour Sneige; Alberto G. Ayala; C. Humberto Carrasco; John Murray; A. Kevin Raymo πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 1 views
Giant cell tumor of bone: Oncologic and
Giant cell tumor of bone: Oncologic and functional results
✍ Auke J. S. Renard; Professor Dr. RenΓ© P. H. Veth; Maciej Pruszczynski; Theo Wobb πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 903 KB

Giant cell tumor of bone is a challenging surgical problem due to its mostly aggressive growth with tendency to recur locally, to develop in rare instances pulmonary metastases without histologic evidence of malignant changes, and due to its potential to dedifferentiate into a frankly malignant tumo